Statistics for Mirtazapine augmentation in treatment-resistant major depressive disorder: an open-label, six-week trial

Total visits

views
Mirtazapine augmentation in treatment-resistant major depressive disorder: an open-label, six-week trial 0

Total visits per month

views
October 2024 0
November 2024 0
December 2024 0
January 2025 0
February 2025 0
March 2025 0
April 2025 0